Experiment 1031660

Details

PropertyValue
Pharmacology
Administration routeEXTERNAL
OrganismEmpty organism
CitationNELSON,KG: STEPHENSON,KB: SLAGA,TJ:. (1982). PROTEIN MODIFICATIONS INDUCED IN MOUSE EPIDERMIS BY POTENT AND WEAK TUMOR-PROMOTING HYPERPLASIOGENIC AGENTS.. 42()
Amount utilized
Compound isolated
DiseaseTHE TITLE COMPOUND CAUSED MANY CHANGES IN THE EPIDERMAL PROTEIN PROFILES ESPECIALLY RELATED TO KERATINS WHICH ARE THE MAJOR DIFFERENTIATION PRODUCT OF THE EPIDERMIS. THE KERATIN MODIFICATION PROGRESSES WITH TIME AFTER TPA TREATMENT, RESULTING IN A KERATIN PATTERN THAT RESEMBLES THAT OF NEWBORN MOUSE EPIDERMIS. PROTEIN ALTERATIONS ARE OBSERVED NOT ONLY EARLY DURING TREATMENT WITH THE TITLE COMPOUND INDUCTION OF HYPERPLASIA AND INFLAMMATION AT 48 AND 72 HOURS,BUT ALSO IN 1- + 2-WEEK SAMPLES IN WHICH THE MORRPHOLOGY OF THE EPIDERMIS HAS RETURNED TO NORMAL.
Dose amount5.0 MCG
Number1
Qualitative resultACTIVE
AnimalMOUSE
Per unitANIMAL
Dose expressionCONC USED
GenderFEMALE